Analyst Danielle Antalffy works at UBS and is focused on Healthcare, Technology sectors with 593 price targets and ratings documented since 2008 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 64.91% with an average time for price targets to be met of 238.92 days.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 20-Jul-2022.
Danielle Antalffy best performing recommendations are on SWAV (SHOCKWAVE MEDICAL, INC).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 12/1/2014. The price target of $35 was fulfilled within 4 days with a profit of $6.15 (21.32%) receiving and performance score of 53.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
388
$6.98 (1.83%)
355
2 months 27 days ago
1/4 (25%)
$72.29 (24.78%)
103
Sell
380
$-1.02 (-0.27%)
235
2 months 27 days ago
5/6 (83.33%)
$-35.88 (-11.57%)
225
Buy
380
$-1.02 (-0.27%)
350
2 months 28 days ago
25/40 (62.5%)
$71.16 (27.20%)
141
Buy
300
$-81.02 (-21.26%)
145
3 months 16 days ago
7/7 (100%)
$13.69 (15.69%)
89
Sell
235
$-146.02 (-38.32%)
275
6 months 14 days ago
15/20 (75%)
$4.31 (1.14%)
236
